Vision protection therapy for prevention of neovascular age-related macular degeneration
Abstract To access the effect of vision protection therapy on neovascular conversion in age-related macular degeneration (AMD). Patient unidentified data aggregated by Vestrum Health, LLC (VH) from over 320 US retina specialists was analyzed to compare the conversion rate from dry to neovascular (we...
Main Authors: | Jeffrey K. Luttrull, Gerry Gray, Sathy V. Bhavan |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-10-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-43605-w |
Similar Items
-
Radiotherapy for neovascular age-related macular degeneration.
by: Evans, JR, et al.
Published: (2010) -
Pemafibrate prevents choroidal neovascularization in a mouse model of neovascular age-related macular degeneration
by: Deokho Lee, et al.
Published: (2023-01-01) -
Experimental Models in Neovascular Age Related Macular Degeneration
by: Olivia Rastoin, et al.
Published: (2020-06-01) -
Characterizing Macular Neovascularization in Myopic Macular Degeneration and Age-Related Macular Degeneration Using Swept Source OCTA
by: Sayah DN, et al.
Published: (2023-12-01) -
Faricimab for the Treatment of Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration
by: Lorenzo Ferro Desideri, et al.
Published: (2023-05-01)